December 16, 2019
The Chase Group has been retained by Genmab in Copenhagen, Denmark, to continue building their drug safety team and is recruiting to secure a Director, Global Drug Safety and Pharmacovigilance physician. This newly created position will report to the Vice President, Head of Global Drug Safety and serve as the expert accountable for the global safety strategy and overall safety profile for the assigned Genmab investigational products throughout their lifecycle. As Genmab works to improve the lives of patients by creating and developing innovative antibody products, The Chase Group is proud to be a partner in securing high caliber talent needed to execute their vision to transform cancer treatment by 2025. For more information please contact ken@chasegroup.com
